Maja T Tomicic Selected Research

Oncogene Proteins (Oncogene Protein)

5/2011

Delayed c-Fos activation in human cells triggers XPF induction and an adaptive response to UVC-induced DNA damage and cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maja T Tomicic Research Topics

Disease

16	Neoplasms (Cancer) 07/2021 - 05/2002
12	Glioma (Gliomas) 07/2021 - 01/2010
10	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 10/2011
4	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 01/2018
3	Melanoma (Melanoma, Malignant) 12/2018 - 08/2013
2	Chromosome Aberrations (Chromosome Abnormalities) 07/2021 - 08/2002
1	Ovarian Neoplasms (Ovarian Cancer) 09/2023
1	Chromosomal Instability (Chromosome Stability) 07/2021
1	Triple Negative Breast Neoplasms 12/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Breast Neoplasms (Breast Cancer) 10/2014
1	Poisoning 01/2013
1	Testicular Neoplasms (Testicular Cancer) 12/2010
1	Hypersensitivity (Allergy) 11/2003
1	Chromosome Breakage 08/2002
1	Necrosis 08/2002
1	Genomic Instability 05/2002

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 07/2021 - 10/2015
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2002
6	SurvivinIBA 07/2021 - 01/2010
5	Small Interfering RNA (siRNA)IBA 12/2018 - 07/2012
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 08/2013 - 10/2011
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2021 - 10/2011
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2013 - 10/2005
2	Cytostatic AgentsIBA 04/2021 - 01/2019
2	IntegrinsIBA 12/2018 - 04/2017
2	EnzymesIBA 01/2018 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 10/2015
2	NimustineIBA 10/2015 - 07/2012
2	Messenger RNA (mRNA)IBA 08/2013 - 07/2012
2	Topoisomerase I InhibitorsIBA 01/2013 - 01/2010
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2013 - 12/2008
1	PlatinumIBA 09/2023
1	TubulinIBA 09/2023
1	taxaneIBA 09/2023
1	Carboplatin (JM8)FDA LinkGeneric 09/2023
1	SenotherapeuticsIBA 07/2021
1	venetoclaxIBA 07/2021
1	O-(6)-methylguanineIBA 07/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2021
1	Vincristine (Oncovin)FDA LinkGeneric 12/2018
1	CilengitideIBA 12/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2018
1	PoisonsIBA 12/2018
1	MethyltransferasesIBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	ran GTP-Binding ProteinIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 04/2017
1	Indicators and Reagents (Reagents)IBA 02/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 12/2016
1	Bcl-2-Like Protein 11IBA 10/2015
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2015
1	Caspase 9IBA 10/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015
1	mafosfamideIBA 10/2014
1	fotemustine (Muphoran)IBA 10/2014
1	Lomustine (CCNU)FDA Link 10/2014
1	exodeoxyribonuclease IIBA 08/2013
1	Exonucleases (3' 5' Exonuclease)IBA 08/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2013
1	CamptothecinIBA 01/2013
1	AlkaloidsIBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 05/2011
1	Cisplatin (Platino)FDA LinkGeneric 12/2010
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2010
1	Topoisomerase II InhibitorsIBA 12/2008
1	trioctyl phosphine oxide (TOPO)IBA 10/2005
1	NucleosidesIBA 08/2002
1	Ganciclovir (Cytovene)FDA LinkGeneric 08/2002
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2002
1	penciclovir (Denavir)FDA Link 08/2002
1	Purine NucleosidesIBA 08/2002
1	Thymidine KinaseIBA 08/2002

Therapy/Procedure

14	Therapeutics 07/2021 - 10/2005
1	Drug Therapy (Chemotherapy) 09/2023
1	Chemoradiotherapy 05/2022
1	Ligation 01/2013